News About: Pharm. Affairs


Kyowa Hakko Kirin’s Neulasta meeting better health insurance benefits

The health insurance standards of Kyowa Hakko Kirin Korea’s Neulasta Prefilled Syringe(generic name: pegfilgrastim) has been partially extensively applied since 1 April. Neulasta is a daily long-acting drug out of gr...

167 products including ‘Iclusig’ newly registered for National Health Insurance Service

Next month, 167 products including a leukemia therapy ‘Iclusig’ will be applied for the National Health Insurance Service. The Ministry of Health and Welfare revised and announced the ‘Drug Insurance Benefits List an...

Fueled competition over hair loss treatment for 10 million patients in Korea

The number of hair loss patients has already exceeded ‘10 million’ in Korea. Multiple statistics analyzed the number will keep increasing in the future. As anyone can easily meet people with the hair loss issue due to...

KRW 70 billion release acetaminophen drug market in danger

The market of release acetaminophen drugs worth of about KRW 70 billion is in danger. The Ministry of Health and Welfare(MFDS) distributed safety letters to medical experts and consumer organizations on the 13th and ...

EC suspends approval of release-type acetaminophen, like Tylenol

The Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) announced on the 13th the ministry has decided to distribute safety letters to pharmaceutical experts and consumer organizations in Korea as the Europ...

Average annual increase rate of pharmacists was lowest compared to other health occupations

Among other types of health care providers, the increase rate of pharmacists was reportedly the lowest 1.2% for the past 6 years. Also, 29,000 of total 34,000 pharmacists were working in pharmacies in 2016. The Mini...

JW Pharmaceutical develops dutasteride tablet for treatment of hair loss and benign prostatic hyperplasia

Developing dutasteride as tablets, JW Pharmaceutical is going to target the world’s KRW 1 trillion market. JW Pharmaceutical announced on the 12th the company succeeded in developing ‘dutasteride,’ a hair loss and be...

11 Korean-developed medicines break the U.S. and EU wall of approval

11 medicines which were developed by Korean pharmaceutical companies after 2013 have reportedly been well sold as breaking the wall of approval of the U.S. and European Union. According to the Ministry of Health and ...

Medicine trade balance was USD 354.5 million this January

The medicine trade balance reportedly recorded USD 354.5 million deficits this January. According to the 2018 January Import and Export Status published by the Korea Customs Service, Korea exported USD 252.9 million ...

Well-developed incrementally modified drugs over new drugs

Incrementally modified drugs with upgraded features from existing approved products have reportedly played key roles for Korean pharmaceutical companies over new drugs which consumed a ton of funds. According to the ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.